Rudi Supriyadi

Rudi Supriyadi

Auto-generated profile, based on publicly available information

Rudi Supriyadi

Department of Internal Medicine , Division of Nephrology and Hypertension , Faculty of Medicine , Hasan Sadikin General Hospital , Padjadjaran University , Bandung , Indonesia , unpad.ac.id

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2020 in Open Access Macedonian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
RSRudi Supriyadi
Rudi Supriyadi
NANenny Agustanti
Nenny Agustanti
MAMarcella Adisuhanto
Marcella Adisuhanto
BACKGROUND: Hepatitis C infection could increase the morbidity and mortality of chronic kidney disease patients on hemodialysis by enhancing the inflammatory process. Tumor Necrosis Factor-alpha (TNF-a) is the main regulator of the inflammatory cascade, which could induce malnutrition and suppress cholesterol and albumin production in the liver. AIM: Therefore, this study aimed to determine the correlation between serum TNF-a level with serum albumin and cholesterol levels in chronic kidney disease patients on hemodialysis with and without hepatitis C infection. METHODS: This research was an analytical cross-sectional study. The sample of this study consisted of patients undergoing routine hemodialysis at Dr. Hasan Sadikin Hospital, Bandung, in February 2020. The sample selection was using a random sampling method and analyzed with the Spearman rank correlation test. RESULTS: One hundred nineteen patients were divided into two groups, with hepatitis C infection (n=53) and without hepatitis C infection (n=66). The median value of serum TNF-α _was higher in the hepatitis C infection group compared to the group without hepatitis c infection (31.86 pg/ml vs 11.71 pg/ml, p <0.001). There was a correlation between serum TNF-α _and cholesterol in the hepatitis C infection (r = -0.246; p = 0.039) and without hepatitis c infection group (r = -0.256; p = 0.022). After adjusting with the duration of hemodialysis, this association was found to be significant in patients without Hepatitis C infection (p = 0.02) and borderline significant in patients with Hepatitis C infection (p = 0.09). There was no correlation between TNF-α _with albumin in both hepatitis C infection group (r = 0.082; p = 0.281) and without hepatitis C infection (r = -0.168; p = 0.094). CONCLUSION: Serum TNF-α _negatively correlates with cholesterol levels in chronic kidney disease patients on hemodialysis with and without hepatitis C infection. However, there was no correlation between TNF-α _and albumin level in both groups.

24 April 2025 in Indonesian Journal of Kidney and Hypertension
Verified
Journal Article
Open access
PDF file
FRFauliza Rakhima
Fauliza Rakhima
RBria bandiara
ria bandiara
RSRudi Supriyadi
Rudi Supriyadi
LDLazuardhi Dwipa
Lazuardhi Dwipa
Background: Sarcopenia is associated with worse outcomes in stage 5 Chronic Kidney Disease on dialysis (CKD 5D) patients, influenced by various diagnostic criteria and patient characteristics. Nonetheless, the factors contributing to sarcopenia in CKD 5D remain underexplored. Objective: To investigate the prevalence and factors associated with sarcopenia in the CKD 5D population. Methods: An observational cross-sectional study was conducted on 132 CKD 5D patients (≥18 years old, dialysis ≥ 3 months) at Hasan Sadikin Hospital from July to August 2024. Descriptive statistics, bivariate analysis, and logistic regression were utilized to determine the prevalence of sarcopenia and its association with the Simplify Creatinine Index (SCI), physical activity, nutritional status, phosphate, and calcium serum levels. Hand Grip Strength (HGS) assessed muscle strength, Bioelectrical Impedance Spectroscopy (BIS) measured muscle mass, the 6-meter walk test evaluated physical performance, and the Asian Working Group for Sarcopenia (AWGS) 2019 criteria were employed for diagnosing sarcopenia. Results: Sarcopenia prevalence was 15.9%. Bivariate analysis revealed significant correlations with underweight (p=0.014), malnutrition (p=0.041), phosphate serum level (p=0.047), and calcium serum level (p=0.043). Logistic regression indicated that higher serum levels of calcium and phosphate and healthy nutritional status, served as protective factors against sarcopenia, with odds ratios of 0.677 (OR 0.677; CI 95% 0.493-0.93 and OR 0.313; CI 95% 0.130-0.755). Conclusion: Sarcopenia prevalence was 15.9%. Phosphate and calcium serum levels, underweight, and malnutrition were significantly correlated with sarcopenia. Higher serum phosphate and calcium levels, higher body weight, and good nutrition status were protective factors against sarcopenia in CKD 5D patients.

1 May 2021 in Journal Of Hypertension
Verified
Journal Article
Open access
RARizky Andhika
Rizky Andhika
RSRudi Supriyadi
Rudi Supriyadi
BABachti Alisjahbana
Bachti Alisjahbana
Background: : Hypertension is associated with poor outcome in patients with Coronavirus Disease-2019 (COVID-19). Several pro-inflammatory markers, such as Absolute Lymphocyte Count (ALC), Neutrophil-to-Lymphocyte Ratio (NLCR), Monocyte-to-Lymphocyte Ratio (MLCR), C-Reactive Protein (CRP), Procalcitonin (PCT), and Ferritin are associated with poor outcome in COVID-19. Pro-inflammatory markers in COVID-19 patients with hypertension is rarely described. Objective: : We aimed to explore several pro-inflammatory markers in COVID-19 patients with hypertension. Methods: We retrospectively analysed confirmed COVID-19 patients between March 1 and August 31, 2020 from Hasan Sadikin General Hospital Bandung. Data were obtained from patient's medical records. Patients with history of hypertension before admission were included in hypertension group. Patients with systolic blood pressure (BP) above 140 mmHg and/or diastolic BP above 90 mmHg on admission, were considered as uncontrolled hypertension. The analysis of data correlation was done using the Pearson correlation, alternative Rank Spearman correlation for non-normal distribution. Results: : We found 140 patients, in which 40 patients were included in hypertension group. NLCR (5.29 vs. 2.92, p = 0.002), MLCR (0.47 vs 0.31, p = 0.001), and CRP (5.62 vs 0.87, p = 0.004) were significantly higher in COVID-19 patients with hypertension. Meanwhile, ALC was found to be lower (1233.9 vs. 1533.9, p = 0.009). PCT (0.05 vs. 0.02, p = 0.079) and ferritin (329.3 vs 224.1, p = 0.073) were higher, but not statistically significant. There was no difference of NLCR, MLCR, CRP, ALC, PCT, and ferritin level between uncontrolled and controlled hypertension group. Conclusion: : COVID-19 patients with hypertension have higher pro-inflammatory markers.

20 June 2025 in International Journal of Innovative Research and Scientific Studies
Verified
Journal Article
Open access
KBKevin Yonatan Budiman
Kevin Yonatan Budiman
LPLukman Pura
Lukman Pura
AAAfiatin Afiatin
Afiatin Afiatin
RSRudi Supriyadi
Rudi Supriyadi
Chronic kidney disease (CKD) poses a significant global health burden with limited therapeutic options to reverse renal function decline. This systematic review and meta-analysis evaluated the effectiveness of mesenchymal stem cell (MSC) interventions in CKD patients by analyzing changes in estimated glomerular filtration rate (eGFR). An electronic search of PubMed, Scopus, EBSCOhost, and ScienceDirect was performed for all articles about MSC therapy for CKD with eGFR as the primary outcome, from January 2015 to March 2025. Data were pooled for analysis with Stata. A total of 13 study groups from ten eligible studies were included, encompassing both controlled and single-arm trials with various MSC sources and dosages. Meta-analysis of controlled studies, which notably all shared the same etiology of diabetic kidney disease, demonstrated a significant improvement in eGFR following MSC therapy compared to controls (mean difference: 10.08 mL/min/1.73 m2; 95% CI: 2.92–17.24; p=0.01), indicating a potential benefit of MSC in enhancing renal function. However, pooled single-arm analyses revealed a non-significant overall eGFR change (mean difference: 1.14 mL/min/1.73 m2; p=0.62) with considerable heterogeneity across studies. MSC therapy shows promise for improving renal function in CKD, particularly in controlled settings with diabetic kidney disease, but further large-scale, standardized randomized trials are necessary to confirm its clinical utility and optimize treatment protocols.

1 January 2026 in International Journal of Hypertension
Verified
Journal Article
Open access
PDF file
MIMaria Riastuti Iryaningrum
Maria Riastuti Iryaningrum
LJLouis Fabio Jonathan Jusni
Louis Fabio Jonathan Jusni
RRRivaldi Ruby
Rivaldi Ruby
RBria bandiara
ria bandiara
YSYunia Sribudiani
Yunia Sribudiani
RSRudi Supriyadi
Rudi Supriyadi
Obesity‐related renal dysfunction is largely attributed to hemodynamic alterations and insulin resistance. Among individuals with overweight or obesity, albuminuria has been shown to be independently and inversely associated with circulating adiponectin levels in the absence of diabetes. Accordingly, this study aimed to evaluate and quantify the independent association between obesity and the risk of kidney disease, as assessed by the presence of albuminuria in the Asian Population. This systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines. A comprehensive and systematic search strategy was applied across multiple electronic databases, including PubMed, ProQuest, Taylor & Francis, and Wiley, to identify relevant studies meeting the eligibility criteria. Data synthesis and statistical analyses were carried out using Review Manager (RevMan) software Version 5.4, and the methodological rigor of the included studies was independently assessed using the Newcastle–Ottawa Scale (NOS). The pooled analysis demonstrated that obesity was significantly associated with albuminuria in the general population as well as in sex‐specific subgroups. Specifically, the odds of albuminuria were higher among individuals with obesity in the overall population (OR = 1.76; 95% CI: 1.09–2.83; p = 0.02, I 2 = 78%), in men (OR = 1.34; 95% CI: 1.05–1.71; p = 0.02, I 2 = 63%), and in women (OR = 1.16; 95% CI: 1.05–1.28; p = 0.004, I 2 = 19%). Obesity was associated with albuminuria in Asian Populations.